Top Markets
#1 DogBull DogBull +108.22%
#2 Siacoin Siacoin +69.25%
#3 ADO Protocol ADO Protocol +58.39%
#4 MarsCoin MarsCoin +52.78%
#5 The Bitcoin Bull The Bitcoin Bull +32.54%
#6 AI XOVIA AI XOVIA +20.71%
#7 Ontology Gas Ontology Gas +19.90%
#8 Stratis Stratis +13.61%
#9 UnifAI Network UnifAI Network +12.65%
#10 Akedo Akedo +11.32%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Rank in Stocks #14604
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Share Price
$0.86785876
Market Cap
$403.51M
Change (1 day)
-1.02%
Change (1 year)
56.42%
Country
SE
Trade Egetis Therapeutics AB (publ) (EGTX)

Category

Healthcare
Stock price history for Egetis Therapeutics AB (publ) (EGTX)
Highest end of day price: $0.87 on 2026-09-01

Lowest end of day price: $2.05 on 2011-04-01
Stock price history of Egetis Therapeutics AB (publ) from 2011 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 16.98%
2025 -9.69%
2024 12.61%
2023 5.26%
2022 -32.21%
2021 -1.08%
2020 -64.01%
2019 24.17%
2018 -26.69%
2017 31.53%
2016 -66.48%
2015 78.45%
2014 56.36%
2013 68.37%
2012 3.47%
2011 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.37 -11.93%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $746.00 4.56%
CH